Page
%P
-
Article
Open AccessPerioperative immunomodulation with interleukin-2 in patients with renal cell carcinoma: results of a controlled phase II trial
We conducted a non-randomised controlled phase II trial to investigate the role of preoperative administration of interleukin-2 (IL-2) in patients with renal cell carcinoma undergoing tumour nephrectomy. A tot...